RecruitingRecruiting
Early Feasibility Study - Edwards APTURE Transcatheter Shunt System
NCT03523416 · Edwards Lifesciences
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
Early Feasibility Study of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW US)
About this study
The early feasibility study of the Edwards APTURE transcatheter shunt system (APTURE system) is a multi-center, prospective, early feasibility study to evaluate initial clinical safety, device functionality, and effectiveness of the APTURE system.
Eligibility criteria
Refined HFrEF Subgroup Inclusion Criteria:
* A primary diagnosis of HFrEF (LVEF ≤ 40%), and
* NYHA Class II, III, or IVa heart failure symptoms and
* Documentation of at least one of the following in the past 12 months, such as:
* Hospitalization for heart failure; or
* Increased treatment for heart failure, including intravenous (IV) or higher-dose diuretic therapy.
* Elevated heart failure biomarker levels (BNP or NT-proBNP) within the past 6 months.
Note: Participants with NYHA Class II symptoms must have both a recent heart failure worsening event and elevated biomarker levels. Participants with NYHA Class III or IVa symptoms must have either a recent heart failure worsening event or elevated biomarker levels.
* Stable Optimized GDMT - Maintained 6 months post-implant (includes stable GLP-1 RA)
Refined HFrEF Subgroup Exclusion Criteria:
* Severe HF defined as one or more of the following:
* Ambulatory NT-proBNP value \>5,000 pg/ml or BNP value \>1,600 pg/ml
* Left ventricular end-diastolic diameter (LVEDD) \>8 cm
* Left ventricular ejection fraction (LVEF) \< 20%
* ACC/AHA Stage D HF or non-ambulatory NYHA Class IV HF
* Inotropic infusion (continuous or intermittent) within the past 6 months
* Active listing on the cardiac transplant waiting list
* More than mild right ventricular dysfunction
* Valve disease
* Mitral regurgitation \> moderate
* Mitral stenosis \> mild
* Tricuspid regurgitation \> moderate
* Aortic regurgitation \> moderate
* Aortic stenosis \> moderate
* Body mass index (BMI) ≥45
* Myocardial infarction and/or any therapeutic invasive, non-valvular cardiac procedure within the past 3 months, or current indication for coronary revascularization
* Stroke, transient ischemic attack, deep vein thrombosis, or pulmonary embolus within the past 6 months
* Cardiac resynchronization therapy implanted within the past 12 months
* Renal insufficiency as determined by serum creatinine (sCr) level \>2.5 mg/dL or estimated glomerular filtration rate (eGFR) \<25 ml/min/1.73 m2
* Performance of the 6-minute walk test with a distance \<100 m or \>450 m
* Active endocarditis or infection requiring intravenous antibiotics within 3 months of scheduled index procedure
* Presence of one or more of the following resting hemodynamic findings:
1. Mean pulmonary capillary wedge pressure (PCWP) \>35 mmHg
2. Mean right atrial pressure (RAP) \>15 mmHg
3. Mean PCWP-mean RAP gradient \< 5 mmHg
4. Pulmonary vascular resistance (PVR) ≥5 Wood Units (WU)
5. Cardiac index \<1.8 L/min/m2
Study design
Enrollment target: 90 participants
Allocation: na
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2018-07-31
Estimated completion: 2032-04
Last updated: 2026-10-02
Interventions
Device: Edwards APTURE transcatheter shunt system
Primary outcomes
- • Rate of major cardiac/cerebrovascular/renal events and re-intervention (Safety Endpoint) (30 days)
Sponsor
Edwards Lifesciences · industry
Contacts & investigators
ContactNatalie Alon · contact · Natalie_Alon@edwards.com · 949-250-1898
ContactMelissa Arteaga · contact · melissa_arteaga@edwards.com · 949-250-2002
All locations (19)
UC San Diego HealthActive Not Recruiting
La Jolla, California, United States
Cedars Sinai Medical CenterWithdrawn
Los Angeles, California, United States
University California San FranciscoActive Not Recruiting
San Francisco, California, United States
University of ColoradoWithdrawn
Aurora, Colorado, United States
University of Florida Health - JacksonvilleActive Not Recruiting
Jacksonville, Florida, United States
St. Vincent Medical GroupCompleted
Indianapolis, Indiana, United States
Kansas University Medical CenterActive Not Recruiting
Kansas City, Kansas, United States
Abbott NorthwesternActive Not Recruiting
Minneapolis, Minnesota, United States
Mayo ClinicActive Not Recruiting
Rochester, Minnesota, United States
Morristown Medical CenterWithdrawn
Morristown, New Jersey, United States
Montefiore Medical CenterActive Not Recruiting
The Bronx, New York, United States
Atrium HealthCompleted
Charlotte, North Carolina, United States
The Christ HospitalActive Not Recruiting
Cincinnati, Ohio, United States
The Ohio State University Medical CenterRecruiting
Columbus, Ohio, United States
Oklahoma Heart InstituteRecruiting
Tulsa, Oklahoma, United States
Oregon Health and Science UniversityActive Not Recruiting
Portland, Oregon, United States
Lankenau Institute for Medical ResearchCompleted
Wynnewood, Pennsylvania, United States
Medical University of South CarolinaActive Not Recruiting
Charleston, South Carolina, United States
Swedish Medical CenterActive Not Recruiting
Seattle, Washington, United States